Table 2.
Rheumatic Diseases | Thrombophilias | |||||
---|---|---|---|---|---|---|
SLE (n = 49) |
Primary APS (n = 40) |
Other RD (n = 17) |
RA (n = 6) |
Primary HT (n = 31) |
p Value * | |
Frequency (%) | ||||||
Secondary SS | 5 (10.2) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.084 |
Secondary APS | 8 (16.3) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.005 |
Secondary Thrombophilia | 10 (20.4) | 10 (25) | 3 (17.6) | 1 (16.7) | - | 0.019 |
Lupus nephritis | 15 (30.6) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0.002 |
Age at first pregnancy, mean (SD) | 31.5 (5.5) | 34.7 (5.1) | 33.70 (5.9) | 36.37 (2.2) | 34.9 (4.9) | 0.014 ** |
Women older than 35 | 13 (26.5) | 20 (50) | 9 (52.9) | 5 (83.3) | 17 (54.8) | 0.015 |
* Comparison of baseline characteristic by pathology (Fisher’s exact test, Kruskal–Wallis test, and Pearson’s Chi-Squared test) ** Multiple comparisons do not have enough statistical power to detect which groups there are differences between multidisciplinary consultation (MC), systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), hereditary thrombophilia (HT), rheumatic disease (RD), rheumatoid arthritis (RA), Sjögren syndrome (SS), and standard deviation (SD).